|
PHARMACOKINETICS OF SUPEROXIDE DISMUTASE MODIFIED WITH LOW ANTICOAGULANT ACTIVITY HEPARIN
|
|
|
低抗凝活性肝素修饰超氧化物歧化酶的药代动力学研究 |
|
PHARMACOKINETICS OF SUSTAINED-RELEASE SODIUM VALPROATE IN 5 CHILDREN WITH EPILEPSY
|
|
|
丙戊酸钠缓释片在5例癫痫儿童的药物动力学 |
|
PHARMACOKINETICS OF THREE ￣(131)I-LABELLED ANTIBODIES IN IMMUNOTARGETING OF HEPATOCELLULAR CARCINOMA
|
|
|
肝癌导向治疗中三种~（131）I标记抗体的药代动力学观察 |
|
PHARMACOKINETICS OF ZINC GLUTAMATE SOLUTION IN RABBITS
|
|
|
谷氨酸锌溶液剂在兔体内的药物动力学研究 |
|
PHARMACOKINETICS OF ~(125)I LABELLED SNAKE VENOM THROMBIN-LIKE ENZYME IN RABBITS
|
|
|
~(125)I尖吻蝮蛇毒凝血样酶在兔体内的药物动力学 |
|
PHARMACOKINETICS STUDIES ON ~3H-ACLACINOMYCIN B IN MICE
|
|
|
~3H-阿克拉霉素B在小鼠体内药代动力学的研究 |
|
PHARMACOKINETICS STUDY OF ANTIEPILEPTIC DRUG SC1001 Na IN RABBITS
|
|
|
抗癫痫新药SC1001Na在家兔体内的药代动力学 |
|
PHARMACOKINETICS STUDY ON THREE FLUOROQUINOLONES
|
|
|
三种氟喹诺酮类抗菌药的药物动力学研究 |
|
PHENOTYPE TRANSITION OF B 7-2 EMBRYONAL CARCINOMA CELLS DURING INDUCED DIFFERENTIATION WITH HEXAMETHYLENEBISACETAMIDE
|
|
|
B7-2胚胎性癌细胞诱导分化过程中的表型转变 |
|
PHF2, M961 and ASH2L: cDNA Cloning and Identification of Their Functions in Induced Differentiation of Multipotential Leukemia Cell Lines
|
|
|
PHF2、M961及ASH2L1全长cDNA克隆及其与人多潜能白血病细胞分化相关性的研究 |
|
PHORBOL DIESTER (TPA)-INDUCED DIFFERENTIATION OF HUMAN LEUKEMIC CELLS IN PRIMARY CULTURE
|
|
|
TPA对原代白血病细胞的诱导分化作用 |
